Cencora, Inc.

NYSE:COR

Medical - Distribution

Healthcare
$348.31 -2.04%

-$5.65 today

Market cap
$66.47B
Beta
0.59
P/E (TTM)
20.7
EPS (TTM)
$13.10
Dividend yield
0.87%
52W Low $244.82High $377.54

Volume 1.20M

Average 1.78M

COR Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

Cencora, Inc.NYSE: COR

Depreciation & Amortization · Q3 FY2026 · quarter ended Jun 2026

Depreciation & amortization growth accelerates

Q3 FY2026 depreciation & amortization of $284.82M rose 11.2% year over year, ahead of the -1.5% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 9.8% from the prior quarter. Over 3 fiscal years it compounded at +14.6% a year.

Context

  • Depreciation & amortization amounted to 0.3% of revenue in FY2025, unchanged from a year earlier.
  • Depreciation & amortization increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +11.2% holds above the trailing-twelve-month pace of -1.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$284.82M+9.8% QoQ
Last fiscal yearSep 2025
$1.07B-4.5% YoY
LTMJun 2026
$1.07B-1.5% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+11.2%——
1 year-4.5%——
3-year CAGR+14.6%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
1.07B USD
Year-over-year change
-4.5%
4-year CAGR
+20.0%

Depreciation & Amortization vs competitors

How COR compares with its peers on the latest reported figures

  • COR's LTM Jun 2026 depreciation & amortization of $1.07B is the highest of the 5 companies compared; the peer median is $547M.
  • Its year-over-year change of -1.5% is the lowest of 5, against a peer median of +12.4%.
  • Depreciation & amortization amounts to 0.3% of revenue for COR, versus a peer median of 1.4%.
COR Competitors Peer median
Depreciation & Amortization for COR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CORCencora, Inc.LTM Jun 2026$1.07B -1.5%+14.6%0.3%
CAHCardinal Health, Inc.LTM Sep 2026$970M +15.3%+11.4%0.4%
MCKMcKesson CorporationLTM Jun 2026$767M +22.9%+6.2%0.2%
HSICHenry Schein, Inc.LTM Jun 2026$327M +9.4%+13.6%2.4%
ACHAccendra Health, Inc.LTM Mar 2026$249.78M -0.8%-2.1%9.2%
Peer median (excluding COR) $547M+12.4%+8.8%1.4%

Competitors are the stored peer set for COR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue213.99B238.59B262.17B293.96B321.33B
Cost of Revenue207.72B230.99B254.42B285.26B311.19B
Gross Profit6.27B7.6B7.76B8.7B10.14B
Gross Margin2.9%3.2%3.0%3.0%3.2%
Research & Development00000
Selling, General & Admin3.59B4.85B5.31B5.66B6.49B
Operating Expenses3.59B4.85B5.31B5.66B6.49B
Depreciation & Amortization514.79M709.84M980.85M1.12B1.07B
EBITDA2.92B3.12B3.42B3.37B3.75B
EBITDA Margin1.4%1.3%1.3%1.1%1.2%
Operating Income2.68B2.75B2.45B3.04B3.65B
Operating Margin1.3%1.2%0.9%1.0%1.1%
Interest Income8.47M21.31M46.72M91.69M128.21M
Interest Expense182.54M231.98M275.65M248.68M419.75M
Other Income / Expenses(453.15M)(568.62M)(285.68M)(1.04B)(1.39B)
Income Before Tax2.22B2.18B2.16B2B2.26B
Pre-Tax Margin1.0%0.9%0.8%0.7%0.7%
Income Tax Expense677.25M516.52M428.26M484.7M690.52M
Net Income1.54B1.7B1.75B1.51B1.55B
Net Margin0.7%0.7%0.7%0.5%0.5%
EPS (Basic)7.488.158.627.608.02
EPS (Diluted)7.398.048.537.537.96
Weighted Avg Shares205.92M208.47M204.59M198.5M193.82M
Weighted Avg Shares (Diluted)208.47M211.21M204.59M200.28M195.21M

Cencora, Inc.

NYSE:COR

Intrinsic Alpha fair value

Locked

Current Price

$348.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.